Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles

Human Reproduction

Volumn 25, Issue 3, 2010, Pages 690-696

  Sipe, Christopher S ^a   Thomas, Mika R ^b   Stegmann, Barbara J ^b   Van Voorhis, Bradley J ^b  

^a Fertility Centers of Illinois   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Gonadotrophins; IVF; Oocytes; Ovary; Testosterone

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; PLACEBO; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEROIDOGENESIS; SUPPLEMENTATION; TRANSVAGINAL ECHOGRAPHY;

EID: 76749159818     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep442     Document Type: Article

References (24)

1. Balasch J, Fábregues F, Peñarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G, Vanrell JA. Pretreatment with transdermal testosterone may improve ovarian response to gonadotropins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 2006;21:1884-1893.
2. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2005a;21:2845-2849.
3. Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005b;84:756.
4. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-634.
5. Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129-2132.
6. Daniel SAJ, Armstrong DT. Enhancement of follicle-stimulation hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology 1980;107:1027-1033.
7. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 2008;23:421-426.
8. Fábregues F, Peñarrubia J, Creus M, Manau D, Casals G, Carmona F, Balasch J. Transdermal testosterone may improve ovarian response to gonadotropins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009;24:349-359.
9. Fasouliotis S, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 2000;17:357-373.
10. Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713-1714.
11. Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986;62:16-21.
12. Harlow CR, Hillier SG, Hodges JK. Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 1986;119:1403-1405.
13. KucukT,KozinogluH,KabaA.Growth hormone co-treatment withinaGnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet 2008;25:123-127.
14. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2009;91:749-766.
15. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod 2006;21:1204-1211.
16. Murray AA, Gosden RG, Allison V, Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 1998; 113:27-33.
17. Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB, Fauser BC. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology 1991a;19:445-452.
18. Pache TD, Hop WCJ, Wladimiroff JW, Schipper J, Fauser BCJM. Transvaginal sonography and abormal ovarian appearance in menstrual cycle disturbances. Ultrasound Med Biol 1991b;17:589-593.
19. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR. Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2007;24:CD004379.
20. Sipe CS, Van Voorhis BJ. Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: a case report. Hum Reprod 1986;22:1380-1383.
21. Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab 1989;69:151-157.
22. Surrey E, Schoolcraft W. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667-676.
23. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629.
24. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956.